1.Curative effect on it is used acute coronary syndrome by Songling Xuemaikang drug
Chinese Journal of Primary Medicine and Pharmacy 2011;18(z2):29-30
ObjectiveTo explore the curative effect about treatment acute coronry syndrome(ACS) by song ling xue mai kang drug used.Methods110 patients with ACS were randomly distributed into treatment group and control group,treatment group included 56 patients,control group included 54 patients,therapy of treatment group added song ling xue mai kang drug base on general treatmnet,but therapy of control group was only general treatment.It was time for four weeks.All patients were examinated blood lipid and C-reactive protein level(CRP) and liver kideny function end of four weeks,and follow-up cardiovascular ischemic event ( reangina attack,remyocardial infarction,heart failure,cardiol vascular death).Results C-reactive protein level of treatment group was less than its of control group,it was significant by statistics test( P <0.01 ).It was significant different about cardiovascular ischemic event between treatment group and control group( P < 0.01 ).ConclusionIt was beneficial to patient of acute coronary syndrome about uesd song ling xue mai kang drug,it could reduce inflammatory reactive to happen in ACS,and reduce badness event of cradiolvascular.
2.Therapeutic effect of trimetazidine on patients with ischemic cardiomyopathy heart failure and significance of plasma level of N-terminal pro-B type natriuretic peptide
Huafa CHEN ; Ronghui ZHOU ; Keyun ZHU
Chinese Journal of Primary Medicine and Pharmacy 2009;16(11):1964-1965
Objective To observe the therapeutic effect of trimetazidine on patients with ischemic cardiomyopathy heart failure and the changes of plasma level of N-terminal pro-B type natriuretic peptide(NT-proBNP).Methods 62 patients with ischemic cardiomyopathy heart failure were randomly assigned to regular treatment group(3 1)and trimetazidine treatment group(31).All of them were given either regular medicine treatment or trimetazidine for 4 weeks.Concentration of NT-proBNP and echocardiography were detected before and after treatment and the correlation between NT-pmBNP and ultra-sound values was studied.Results There was no statistic difference in the NT-proBNP level between two groups before treatment,but after 4-week treatment the NT-proBNP level in both groups were deCreased(P<0.05),the decline in the trimetazidine group was more significant.The NT-proBNP level was significantly correlated to LVEF and LVEDD(γ=-0.472、0.45 1;P<0.05).Conclusions Trimetazidine has a positive effect on patients with ischemic cardiomyopathy heart failure,and decreases the plasma NT-proBNP level.NT-proBNP Can be used as a follow-up index.
3.An Experiment Study on the Effect of Heat Stress on Plasma cGMP in Animals with Chronic Heart Failure
Keyun ZHU ; Weiguo TAO ; Xiangyang FU
Journal of Chinese Physician 2001;0(08):-
Objective To observe the effect of heat stress on plasma cGMP and hemodynamics in animals with chronic heart failure. Methods Coronary arteries of twenty-five rabbits were ligated to set up the animal model of heart failure and other five rabbits only received thoractomy as sham group. Eight weeks after coronary artery ligation, they are randomly divided into heat stress (HS) group, control group, HS+L-NAME group, and non-HS+L-NAME group and non-HS+L-Arg group, each group containing 5 animals. Hemodynamic indices and plasma levels of NOS and cGMP were measured. Results Hemodynamics of all 25 rats received operation was poorer compared with the rats of sham group (P
4.Research Progress on the Relationship between Metabolic Syndrome and Triple-Negative Breast Cancer
Yao TIAN ; Yi WANG ; Keyun ZHU ; Baichuan WANG ; Xuchen CAO
Tianjin Medical Journal 2014;(9):953-955,956
Metabolic syndrome (MS) and breast cancer are common diseases of women. Triple negative breast cancer (TNBCs) is one type of breast cancer, which is of much attention in recent years. Important components of MS include central obesity, high blood sugar, high triglycerides and low level of high-density lipoprotein (HDL-C), which increased the inci-dence risk of TNBCs. Common biomarkers of MS including insulin, adiponectin and leptin play an important role in the oc-currence and development of breast cancer, especially TNBCs. Insulin-like growth factor-IImRNA binding protein 3 (IMP3, an oncofetal protein) may be TNBCs’new invasive cancer biomarkers. In this paper, the research progress on the relation-ship between MS and TNBCs is reviewed.
5.Relationship between placental growth factor and acute coronary syndrome
Weiguo TAO ; Zhuanhe LIANG ; Huafa CHEN ; Keyun ZHU
Chinese Journal of Primary Medicine and Pharmacy 2009;16(6):977-978
Objecitve To investigate the relationship between placental growth factor and acute coronary syndrome(ACS). Methods 70 cases of patients with acute chest pain were enrolled. 36 cases of patients who is posi-tive on cardiac troponin T(cTnT) as treatment group, 24 patients who is negative on cTnT as control group, blood of all patients were detected about PLGF and cTnT in hospital,and coromary angiography examination, Gemini score is used to evaluate coronary artery lesion. Result PLGF and cTnT were elevated in ACS, it had significant difference between two groups(P <0. 01) ,PLGF and cTnT are significantly positive correlated(r= 1.2,P <0. 01), PLGF and cornorary artery lesion severity are significantly positive correlated(r = 1 ,P <0. 01). Conclusion PLGF is helpful to predict ACS attack to comorary heart disease,higher PLGF predicts unstable to coronary artery lesion in coronary heart disease.
6.Therapeutic effect of combined medication of amlodipine and captopril on patients with hypertension complicated with coronary heart disease
Weiguo TAO ; Zhuanhe HANG ; Huafa CHEN ; Keyun ZHU
Chinese Journal of Primary Medicine and Pharmacy 2009;16(2):259-260
Objectlve To study the therapeutic efficacy of the combined medication of ShiHuiDa and capto pril on patients with by Opertension and coronary heart disease.Methods 80 patients witll hypertension complicated with coronary disease were included in this study.They were randomly dirided in to treatment group and control group,every group is forty patients.Treatment group treated by ShiHuiDa and captopril,control group treated by hydrocblorothiazide nitrendipine and dinitrosorbide.Blood pressure angina pectoris relief and electrocardlogram were observed after eight weeks therapy.Results Systolic pressure and diastolic pressure in treatment group is less than control group,it is obviously better than control group about depressurization effect,it has significant difference by statistical test.Angina pectoris relief rate and electrocardiogram improve rate in treatment group is better than control group,it has significant difference.Conclusion The combined medication of ShiHuiDa and captopril is not only effective in lowering blood pressure and stronger and persistence,but also in relieving angna pectoris attack.
7.Radiofrequency catheter ablation in frequently single premature ventricular beats
Huafa CHEN ; Keyun ZHU ; Zhuanhe LIANG ; Weiguo TAO
Chinese Journal of Primary Medicine and Pharmacy 2006;0(07):-
Objective To discuss curative effect about radio frequently catheter ablation(RFCA) in frequently single originating premature ventricular beats.Methods 19 patients with frequently single original premature ventricular beats.The site of orgin was determined by activation mapping for the earliest endocardial activation,and by pace mapping for the exact QRS pacing site.Results 18 patients operation obtained immediate success,1 patient was failure,but no complication happened.After RFA in 2 weeks 24 hour Hoter ECG was used to examine arrhythmia condition,and all cases were follow up for 6~24 months after RFA,there were 17 patients who had no recurrence or phenomenon of premature beats augument,1 patient showed other type premature ventricular bearts.Conclusion It is safe and effective about RFA in frequently single origin premature ventricular beats of outflow lane.
8.Protective effect of ethyl acetate extract of Pongamia pinnata roots on ethanol-induced gastric mucosal injuries in rats
Keyun LIU ; Yi ZHU ; Zhi DONG ; Jing LI ; Ling HUANG ; Guobiao CHEN
Chinese Journal of Pharmacology and Toxicology 2007;21(6):476-481
AIM To investigate the therapeutic effect of ethyl acetate extract from Pongamia pinnata roots (PREA) on ethanol-induced gastric lesions. METHODS The experimental gastric mucosal injuries were prepared by ig ethanol to rats, and the protective effect of PREA was evaluated by calculating lesion index, observing pathological changes, and measuring the contents of nitric oxide (NO) and malondialdehyde (MDA), and the activity of superoxide dismutase (SOD) from gastric mucosal tissue. In addition, gastric secretary and gastric wall adherent mucus were studied with the pylorus-ligation rat model. RESULTSCompared with the model control group, PREA (50, 150 and 450 mg·kg-1, ig) dose-dependently prevented the gastric mucosal damages induced by ethanol, its inhibition rates were 28.7%, 57.7% and 78.7 %, respectively. The pathomorphology lesions of mucosal tissue were obviously ameliorated. PREA obviously antagonized the ethanol-induced elevation of MDA content, and reduction of NO level and SOD activity of gastric mucosa. PREA significantly reduced gastric juice volume, free acidity, total acidity and total acid output, but didn′t affect the pepsin activity. Moreover, PREA obviously increased adherent mucus quantity of stomach wall, as well as free mucus quantity dissolved in gastric juice of pylorus-ligation rat. CONCLUSIONPREA has protective effect on ethanol-induced gastric mucosal injuries, which suggests that PREA may be used for protection or treatment of human ethanolinduced gastric lesions.
9.Experimental study on anti-inflammation and analgesia effect and acute toxicity of extract from Pongamia pinnata roots
Keyun LIU ; Yi ZHU ; Zhi DONG ; Guobiao CHENG ; Yumei ZHAO ; Bei LI ; Chun LIU ; Jin LI
Chinese Traditional Patent Medicine 2007;29(2):179-183
AIM: To study the effect of extract from Pongamia pinnata roots on anti-inflammation and analgesia and acute toxicity. METHODS: The models of mice ear edema induced by xylene and Cotton pellet granuloma in rats to observe the anti-inflammation effect of PRE via oral administration. The effect of PRE on analgesia was tested by measuring the latent period licking hind foot with the hot plate method and counting body twisting induced by acetic acid in mice. The acute toxicity of PRE was measured by the method of Bliss. RESULTS: PRE could significantly inhibit the ear edema caused by xylene in mice, granuloma hyperplasia caused by cotton in rats. It could significantly prolong the pain threshold on hot-plate in mice, reduce the writhing times in mice. The LD50 of PRE was 6. 371 8 g/kg, its 95% confident limit was 5. 408 4-7. 723 2 g/kg. CONCLUSION: PRE has obvious effect on anti-inflammation and analgesia and the lower acute toxicity.
10.Influence of Metformin on Metabolic Syndrome in Patients With Coronary Artery Disease
Huafa CHEN ; Jianqiao TAN ; Ronghui ZHOU ; Keyun ZHU ; Weiguo TAO ; Zhuanhe LIANG
Chinese Journal of Primary Medicine and Pharmacy 2010;17(1):44-46
Objective To investigate the influence of metformin on metabolic syndrome in patients with coronary artery disease.Methods 52 patients with coronary artery disease and metabolic syndrome were randomly assigned into 2 groups.the control group with 20 cases and the study group with 32 cases.All the patients were treated with standard coronary artery disease therapy and meanwhile the study group was administered with metformin in addition to the basic therapy above.The follow-up time is one year.FPG,2h postprandial glucose,FINS,TG,TC,HDL-C,insulin resistance index and other standards were compared before and after the therapy,and between the 2 groups when the observation was finished.The rate of cardiovascular events was also compared between the 2 groups.Results Compared with the control group,the study group had lower levels of FPG,2h postprandial glucose,FINS,TG and insulin resistance index when the therapy was completed(P<0.05),and the rate of cardiovascular events was also lower(P<0.05).Conclusion Metformin could lower the levels of glucose,FINS,BMI,TG and insulin resistance index in patients with coronary artery disease and metabolic syndrome.Thus,it could reduce and undermine cardlovascular risk factors,protect the cardiovascular system,reduce the rate of cardiovascular events,which fully benefits the patients.